NCT07274813 2026-03-03
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase EARLY_PHASE1 Recruiting
Shanghai Henlius Biotech
St. Jude Children's Research Hospital
Zhejiang University
Beijing Geekgene Technology Co., LTD